In vivo stability and distribution of [131I]iodomethyl trimethylammonium chloride: concise communication.
[131I]iodomethyl trimethylammonium chloride (I-131 TMA) was prepared by the isotope-exchange reaction of diiodomethane with Na131I, followed by reaction with trimethylamine. A specific activity of 20 microCi/mg was obtained. Tissue distributions following intravenous injection of I-131 TMA in mice showed that between 10 min and 2 hr, the highest accumulations of radioactivity were in the urine, kidney, and heart. The uptake of this compound in the heart was very rapid, and the levels of radioactivity remained fairly high up to 2 hr. At 10, 30, 60, and 120 min the heart-to-blood ratios were, respectively, 10.2, 7.7, 8.3, and 9.6. Thyroid uptake of this compound in the rats and analysis of urine samples of the mouse indicated no extensive deiodination of the compound in vivo. These results show that this compound does have potential for use in myocardial imaging. In addition, its stability in vivo makes it very useful for the radiolabeling of compounds containing quaternary ammonium moieties.
D000818:Animals; D003327:Coronary Disease / Q000000981:diagnostic imaging; D004355:Drug Stability; D005260:Female; D007457:Iodine Radioisotopes; D008297:Male; D051379:Mice; D000644:Quaternary Ammonium Compounds / Q000378:metabolism; D011877:Radionuclide Imaging; D051381:Rats; D014018:Tissue Distribution
D007457:Iodine Radioisotopes; D000644:Quaternary Ammonium Compounds; C025659:iodotrimethylammonium